Is PCSK9 a marker of early vascular disease?
This study suggests that measurement of PCSK9 could be used as a predictor of early vascular disease in the primary prevention setting. Previous reports have suggested the potential of PCSK9 as a possible biomarker of risk for clinical ischaemic events. This study investigated this in…read more »
Posted on 11 July 2017 | Posted in News
Plasma PCSK9 levels higher in PAD
Atherosclerotic peripheral artery disease (PAD) affects more than 200 million people worldwide (1), and is associated with substantial morbidity. More than 50% of people with PAD have concomitant coronary heart disease, cerebrovascular disease, or both (2). Management of more severe disease is costly; in the…read more »
Posted on 13 July 2016 | Posted in News